Eric Adler

Insider Reports History

Location
New York, NY
Signature
/s/ Youjin Choi, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Eric Adler:

Company Role Class Num Shares Value Price $ Report Date Ownership
Lexeo Therapeutics, Inc. Chief Medical Officer Common Stock 72,646 $673,428 $9.27 18 Nov 2025 Direct
Lexeo Therapeutics, Inc. Chief Medical Officer Stock Option (right to buy) 87,500 07 Jan 2025 Direct

Insider Reports Filed by Eric Adler

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LXEO Lexeo Therapeutics, Inc. 18 Nov 2025 1 -$5,701 4 Chief Medical Officer 20 Nov 2025, 17:20
LXEO Lexeo Therapeutics, Inc. 15 Oct 2025 3 -$30,242 4 Chief Medical Officer 17 Oct 2025, 19:26
LXEO Lexeo Therapeutics, Inc. 18 Aug 2025 1 -$2,838 4 Chief Medical Officer 20 Aug 2025, 17:02
LXEO Lexeo Therapeutics, Inc. 16 May 2025 1 -$1,623 4 Chief Medical Officer 20 May 2025, 17:00
LXEO Lexeo Therapeutics, Inc. 19 Feb 2025 1 -$10,410 4 Chief Medical Officer 21 Feb 2025, 17:09
LXEO Lexeo Therapeutics, Inc. 07 Jan 2025 2 $0 4 Chief Medical Officer 10 Jan 2025, 16:55
LXEO Lexeo Therapeutics, Inc. 02 Feb 2024 2 $0 4 Chief Medical Officer 06 Feb 2024, 17:56
LXEO Lexeo Therapeutics, Inc. 02 Nov 2023 0 $0 3 Chief Scientific Officer 02 Nov 2023, 21:14